Evidence map›Paper›PMID 38913731›Full record

ArticlePLoS computational biology2024

Logistic PCA explains differences between genome-scale metabolic models in terms of metabolic pathways.

Leopold Zehetner, Diana Széliová, Barbara Kraus, Juan A Hernandez Bort, Jürgen Zanghellini

Abstract read
In one paragraph

Article in PLoS computational biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leopold ZehetnerDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.ORCID 0009-0003-2677-3685
Diana SzéliováDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.ORCID 0000-0002-9885-9758
Barbara KrausGene Therapy Process Development, Baxalta Innovations GmbH, a Part of Takeda Companies, Orth an der Donau, Austria.
Juan A Hernandez BortGene Therapy Process Development, Baxalta Innovations GmbH, a Part of Takeda Companies, Orth an der Donau, Austria.ORCID 0000-0003-2348-4864
Jürgen ZanghelliniDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.ORCID 0000-0002-1964-2455

Funding

Baxalta Innovation GmbHUniversity of Vienna
6 · The paper itself

Abstract

Genome-scale metabolic models (GSMMs) offer a holistic view of biochemical reaction networks, enabling in-depth analyses of metabolism across species and tissues in multiple conditions. However, comparing GSMMs Against each other poses challenges as current dimensionality reduction algorithms or clustering methods lack mechanistic interpretability, and often rely on subjective assumptions. Here, we propose a new approach utilizing logisitic principal component analysis (LPCA) that efficiently clusters GSMMs while singling out mechanistic differences in terms of reactions and pathways that drive the categorization. We applied LPCA to multiple diverse datasets, including GSMMs of 222 Escherichia-strains, 343 budding yeasts (Saccharomycotina), 80 human tissues, and 2943 Firmicutes strains. Our findings demonstrate LPCA's effectiveness in preserving microbial phylogenetic relationships and discerning human tissue-specific metabolic profiles, exhibiting comparable performance to traditional methods like t-distributed stochastic neighborhood embedding (t-SNE) and Jaccard coefficients. Moreover, the subsystems and associated reactions identified by LPCA align with existing knowledge, underscoring its reliability in dissecting GSMMs and uncovering the underlying drivers of separation.

Indexed as

Metabolic Networks and PathwaysModels, BiologicalPrincipal Component AnalysisAlgorithmsCluster AnalysisComputational BiologyGenomeHumansPhylogeny

Identifiers

PMID38913731
PMCPMC11226097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.